Predicting the Double Heterozygotes of HbE and α-Thalassemia-1 (Southeast Asian Type) Using RapidMiner-Generated Hematologic Algorithm.

IF 1 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY
Hemoglobin Pub Date : 2025-11-01 Epub Date: 2025-11-24 DOI:10.1080/03630269.2025.2590224
Thanusak Tatu, Saitarn Klasamut, Hathaikan Sorntham, Prasert Chantanaskulwong, Nutchanin Kaewkhampa, Pisuttinee Khantarag
{"title":"Predicting the Double Heterozygotes of HbE and α-Thalassemia-1 (Southeast Asian Type) Using <i>RapidMiner</i>-Generated Hematologic Algorithm.","authors":"Thanusak Tatu, Saitarn Klasamut, Hathaikan Sorntham, Prasert Chantanaskulwong, Nutchanin Kaewkhampa, Pisuttinee Khantarag","doi":"10.1080/03630269.2025.2590224","DOIUrl":null,"url":null,"abstract":"<p><p>Double heterozygotes of HbE and α-Thalassemia-1 (Southeast Asian type) ((β<sup>A</sup>/β<sup>E</sup>, - -SEA/αα) can result in severe thalassemia conditions, such as HbE/β-thalassemia (β<sup>E</sup>/β<sup>T</sup>)) and Hb Bart's hydrops fetalis syndrome (- -<sup>SEA</sup>/- -<sup>SEA</sup>). Identification of these double heterozygotes is crucial for preventing births affected by Hb Bart's hydrops fetalis syndrome. The most accurate method for detecting HbE/SEA-α-Thalassemia-1 double heterozygotes is PCR-based analysis, which is complex and costly. This study aimed to develop a hematologic algorithm for predicting double heterozygotes of HbE/SEA-α-Thalassemia-1. A retrospective analysis was conducted on 471 datasets of red blood cell indices and HbE levels collected from hospitals in Northern Thailand. Data analysis and algorithm development were performed using statistical tools and <i>RapidMiner</i> software. The prevalence of HbE/SEA-α-Thalassemia-1 double heterozygotes was 12.1%. Significant differences were found in HbE levels, MCV, MCH, and RBC count between single HbE heterozygotes and HbE/SEA-α-Thalassemia-1 double heterozygotes. The predictive algorithm, named the '<i>Nation SEAE Algorithm</i>,' was established as follows: HbE ≤ 20.5%; RBC > 4.55 × 10<sup>6</sup>/µL; and MCV ≤ 70.5 fL. This algorithm demonstrated 40% sensitivity (95% CI: 30.3-50.3), 100% specificity (95% CI: 96.4-100), 100% positive predictive value (95% CI: 96.4-100), 95.6% negative predictive value (95% CI: 90.0-98.9), a negative likelihood ratio of 0.6 (95% CI: 0.3-1.2), an infinite positive likelihood ratio, 95.7% accuracy (95% CI: 90.1-98.9), and an area under the ROC curve of 0.99 (95% CI: 0.97-1.00) for identifying HbE/SEA-α-Thalassemia-1 double heterozygotes. Therefore, the '<i>Nation SEAE Algorithm</i>' is a valuable clinical tool to support accurate identification of the double heterozygotes of HbE and SEA-α thalassemia 1.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"390-398"},"PeriodicalIF":1.0000,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hemoglobin","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03630269.2025.2590224","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/24 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Double heterozygotes of HbE and α-Thalassemia-1 (Southeast Asian type) ((βA/βE, - -SEA/αα) can result in severe thalassemia conditions, such as HbE/β-thalassemia (βE/βT)) and Hb Bart's hydrops fetalis syndrome (- -SEA/- -SEA). Identification of these double heterozygotes is crucial for preventing births affected by Hb Bart's hydrops fetalis syndrome. The most accurate method for detecting HbE/SEA-α-Thalassemia-1 double heterozygotes is PCR-based analysis, which is complex and costly. This study aimed to develop a hematologic algorithm for predicting double heterozygotes of HbE/SEA-α-Thalassemia-1. A retrospective analysis was conducted on 471 datasets of red blood cell indices and HbE levels collected from hospitals in Northern Thailand. Data analysis and algorithm development were performed using statistical tools and RapidMiner software. The prevalence of HbE/SEA-α-Thalassemia-1 double heterozygotes was 12.1%. Significant differences were found in HbE levels, MCV, MCH, and RBC count between single HbE heterozygotes and HbE/SEA-α-Thalassemia-1 double heterozygotes. The predictive algorithm, named the 'Nation SEAE Algorithm,' was established as follows: HbE ≤ 20.5%; RBC > 4.55 × 106/µL; and MCV ≤ 70.5 fL. This algorithm demonstrated 40% sensitivity (95% CI: 30.3-50.3), 100% specificity (95% CI: 96.4-100), 100% positive predictive value (95% CI: 96.4-100), 95.6% negative predictive value (95% CI: 90.0-98.9), a negative likelihood ratio of 0.6 (95% CI: 0.3-1.2), an infinite positive likelihood ratio, 95.7% accuracy (95% CI: 90.1-98.9), and an area under the ROC curve of 0.99 (95% CI: 0.97-1.00) for identifying HbE/SEA-α-Thalassemia-1 double heterozygotes. Therefore, the 'Nation SEAE Algorithm' is a valuable clinical tool to support accurate identification of the double heterozygotes of HbE and SEA-α thalassemia 1.

利用rapidminer生成的血液学算法预测HbE和α-地中海贫血-1(东南亚型)的双杂合子
HbE和α-地中海贫血-1(东南亚型)((βA/βE, - - sea /αα)的双杂合子可导致严重的地中海贫血,如HbE/β-地中海贫血(βE/βT))和Hb Bart's hydrops胎儿综合征(- - sea /- - sea)。鉴别这些双杂合子对于预防出生受巴特氏胎儿水肿综合征的影响至关重要。检测HbE/SEA-α-Thalassemia-1双杂合子最准确的方法是基于pcr的分析,该方法复杂且成本高。本研究旨在建立预测HbE/SEA-α-地中海贫血-1双杂合子的血液学算法。回顾性分析了从泰国北部医院收集的471个红细胞指数和HbE水平数据集。使用统计工具和RapidMiner软件进行数据分析和算法开发。HbE/SEA-α-地中海贫血-1双杂合子患病率为12.1%。HbE单杂合子与HbE/SEA-α-Thalassemia-1双杂合子在HbE水平、MCV、MCH和RBC计数上存在显著差异。建立预测算法,命名为“Nation SEAE算法”,HbE≤20.5%;RBC > 4.55 × 106/µl;MCV≤70.5 fL。该算法识别HbE/SEA-α-Thalassemia-1双杂合子的灵敏度为40% (95% CI: 30.3-50.3),特异性为100% (95% CI: 96.4-100),阳性预测值为100% (95% CI: 96.4-100),阴性预测值为95.6% (95% CI: 90.0-98.9),阴性似然比为0.6 (95% CI: 0.3-1.2),无限阳性似然比为95.7% (95% CI: 90.1-98.9), ROC曲线下面积为0.99 (95% CI: 0.97-1.00)。因此,“national SEAE算法”是一种有价值的临床工具,可以支持准确鉴定HbE和SEA-α地中海贫血1的双杂合子。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hemoglobin
Hemoglobin 医学-生化与分子生物学
CiteScore
1.70
自引率
10.00%
发文量
59
审稿时长
3 months
期刊介绍: Hemoglobin is a journal in the English language for the communication of research and information concerning hemoglobin in humans and other species. Hemoglobin publishes articles, reviews, points of view The journal covers topics such as: structure, function, genetics and evolution of hemoglobins biochemical and biophysical properties of hemoglobin molecules characterization of hemoglobin disorders (variants and thalassemias), consequences and treatment of hemoglobin disorders epidemiology and prevention of hemoglobin disorders (neo-natal and adult screening) modulating factors methodology used for diagnosis of hemoglobin disorders
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书